Digital Diabetes Management Solutions

https://phti.com/assessment/digital-diabetes-management-tools/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=299346057&_hsenc=p2ANqtz-_ZwcbYhL6h1ICLxLz1cYLDf3yoSdUCPVxAsZf1GeuXYm5ONXSfsbO1PZdVyr-xOaK83_8luSuysTqZs1B0I4m6b3wVMg&utm_content=299346057&utm_source=hs_email Digital health tools didn't deliver savings in diabetes monitoring, study says Digital health companies have promised to improve the lives of 38 million Americans with type 2 diabetes, pitching fingerstick monitoring of blood glucose as a way to prevent amputation, kidney failure, and other serious complications. A new study paints a bleak picture of the approach, saying the digital tools cost more than they were worth. That could be challenging for companies like Teladoc, Omada, and DarioHealth that offer digital diabetes products. A systematic review by the Peterson Health Technology Institute found that the digital tools to manage diabetes from eight companies didn’t result in clinically meaningful improvements over standard care. Instead of reducing health care spending, they drove it up. Some populations might benefit, but current evidence doesn’t support broader adoption for most products, the report says. The institute is a nonprofit launched last July to independently evaluate costs and clinical outcomes for new digital health products. STAT’s Katie Palmer and Mario Aguilar have more, including company perspectives. https://www.statnews.com/2024/03/21/diabetes-management-digital-tools-efficacy-cost-teladoc-omada/?utm_campaign=rss&_hsmi=299346057&_hsenc=p2ANqtz--AyZc8b_s70nR_EG36K4DWtCxPFpr5n6R0YfKRD0Fo3pE7Aj7ivd4yMddoPeqxQLA4oW84IIir16PEV10o4Jqd4_9bYw